They also reported that SOX9 enhanced the proliferation, invasion, and migration of gastric cancer cells, and SOX9 may enhance the epithelial–mesenchymal transition (EMT) in gastric cancer cells via the Hippo-YAP pathway [61], supporting the notion that the Hippo-YAP pathway plays a critical role in gastric cancer progression. Here, SOX9 is linked to gastric cancer.